- Home
- APXT vs FDMT Comparison
APXT vs FDMT Comparison
Compare APXT & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APXT | FDMT |
|---|---|---|
| Founded | 2025 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 454.1M | 455.4M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | APXT | FDMT |
|---|---|---|
| Price | $9.88 | $7.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $30.33 |
| AVG Volume (30 Days) | 78.3K | ★ 1.2M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,000.00 |
| Revenue This Year | N/A | $21,181.08 |
| Revenue Next Year | N/A | $162.43 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 605.88 |
| 52 Week Low | $9.87 | $2.24 |
| 52 Week High | $9.96 | $12.34 |
Technical Indicators
Market Signals| Indicator | APXT | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 38.11 |
| Support Level | N/A | $6.96 |
| Resistance Level | N/A | $11.81 |
| Average True Range (ATR) | 0.00 | 0.69 |
| MACD | 0.00 | -0.11 |
| Stochastic Oscillator | 0.00 | 16.91 |
Price Performance
Historical ComparisonAbout APXT Apex Treasury Corporation Class A Ordinary Share
Apex Treasury Corp is a blank check company established for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.